ATE164079T1 - Verfahren zur behandlung von parasitären infektionen unter verwendung von ige-antagonisten - Google Patents
Verfahren zur behandlung von parasitären infektionen unter verwendung von ige-antagonistenInfo
- Publication number
- ATE164079T1 ATE164079T1 AT95907302T AT95907302T ATE164079T1 AT E164079 T1 ATE164079 T1 AT E164079T1 AT 95907302 T AT95907302 T AT 95907302T AT 95907302 T AT95907302 T AT 95907302T AT E164079 T1 ATE164079 T1 AT E164079T1
- Authority
- AT
- Austria
- Prior art keywords
- parasitic infections
- treating parasitic
- ige antagonists
- ige
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18408394A | 1994-01-18 | 1994-01-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE164079T1 true ATE164079T1 (de) | 1998-04-15 |
Family
ID=22675480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95907302T ATE164079T1 (de) | 1994-01-18 | 1995-01-05 | Verfahren zur behandlung von parasitären infektionen unter verwendung von ige-antagonisten |
Country Status (10)
Country | Link |
---|---|
US (1) | US5656273A (de) |
EP (1) | EP0739214B1 (de) |
JP (1) | JP3825798B2 (de) |
AP (1) | AP660A (de) |
AT (1) | ATE164079T1 (de) |
DE (1) | DE69501817T2 (de) |
DK (1) | DK0739214T3 (de) |
MX (1) | MX9602818A (de) |
PH (1) | PH31447A (de) |
WO (1) | WO1995019181A1 (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL137649A (en) * | 1998-02-18 | 2004-08-31 | Genentech Inc | Method of adsorption chromatography |
WO2000015260A1 (en) * | 1998-09-16 | 2000-03-23 | Tanox, Inc. | Anti-ige gene therapy |
EP1113818B1 (de) * | 1998-09-18 | 2006-05-17 | Dynavax Technologies Corporation | Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren |
CA2446108A1 (en) * | 2001-05-11 | 2002-11-21 | Novartis Ag | Compositions for use in treating ige-associated disorders |
WO2002094228A1 (en) * | 2001-05-23 | 2002-11-28 | David Follansbee | Prevention and treatment of allergies by helminthic regulation of ige |
ATE417858T1 (de) | 2002-02-05 | 2009-01-15 | Genentech Inc | Proteinaufreinigung |
JP4319979B2 (ja) | 2002-04-26 | 2009-08-26 | ジェネンテック・インコーポレーテッド | タンパク質の非アフィニティ精製 |
US20070178082A1 (en) * | 2002-11-08 | 2007-08-02 | Ablynx N.V. | Stabilized single domain antibodies |
US9320792B2 (en) | 2002-11-08 | 2016-04-26 | Ablynx N.V. | Pulmonary administration of immunoglobulin single variable domains and constructs thereof |
US20100003253A1 (en) * | 2002-11-08 | 2010-01-07 | Ablynx N.V. | Single domain antibodies directed against epidermal growth factor receptor and uses therefor |
WO2004041865A2 (en) * | 2002-11-08 | 2004-05-21 | Ablynx N.V. | Stabilized single domain antibodies |
US20060034845A1 (en) * | 2002-11-08 | 2006-02-16 | Karen Silence | Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
HUE050171T2 (hu) | 2003-07-28 | 2020-11-30 | Genentech Inc | Protein-A kioldódásának csökkentése protein-A affinitáskromatográfia során |
US20050065136A1 (en) * | 2003-08-13 | 2005-03-24 | Roby Russell R. | Methods and compositions for the treatment of infertility using dilute hormone solutions |
US20050239757A1 (en) * | 2004-04-21 | 2005-10-27 | Roby Russell R | Hormone treatment of macular degeneration |
US20060025390A1 (en) * | 2004-07-28 | 2006-02-02 | Roby Russell R | Treatment of hormone allergy and related symptoms and disorders |
US7662926B2 (en) | 2004-09-02 | 2010-02-16 | Genentech, Inc. | Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor |
US7655229B2 (en) | 2004-09-02 | 2010-02-02 | Chan Andrew C | Anti-FC-gamma RIIB receptor antibody and uses therefor |
JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
JP2007172129A (ja) * | 2005-12-20 | 2007-07-05 | Sony Corp | 不揮発性メモリアクセス制御装置および不揮発性メモリ制御システム |
FR2902799B1 (fr) | 2006-06-27 | 2012-10-26 | Millipore Corp | Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide |
US20110105559A1 (en) * | 2006-09-11 | 2011-05-05 | Rohrs Brian R | Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy |
CN101553214B (zh) * | 2006-09-11 | 2012-12-26 | 博士伦公司 | 用于治疗、控制、减轻、改善或预防变态反应的组合物和方法 |
US20110104159A1 (en) * | 2006-09-11 | 2011-05-05 | Rohrs Brian R | Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
US20100267933A1 (en) | 2006-12-21 | 2010-10-21 | Moya Wilson | Purification of proteins |
US8569464B2 (en) | 2006-12-21 | 2013-10-29 | Emd Millipore Corporation | Purification of proteins |
US8362217B2 (en) | 2006-12-21 | 2013-01-29 | Emd Millipore Corporation | Purification of proteins |
AU2008209404B2 (en) | 2007-01-22 | 2012-08-16 | Genentech, Inc. | Polyelectrolyte precipitation and purification of antibodies |
LT3597659T (lt) | 2007-07-09 | 2023-05-10 | Genentech, Inc. | Disulfidinės jungties redukcijos prevencijos būdas gaminant polipeptidą rekombinantiniu būdu |
SG175597A1 (en) | 2007-10-30 | 2011-11-28 | Genentech Inc | Antibody purification by cation exchange chromatography |
US8999702B2 (en) | 2008-06-11 | 2015-04-07 | Emd Millipore Corporation | Stirred tank bioreactor |
ES2527943T5 (es) | 2008-08-14 | 2019-03-07 | Genentech Inc | Métodos para eliminar un contaminante usando cromatografía de membrana de intercambio iónico de desplazamiento de proteínas |
MX2011002372A (es) | 2008-09-10 | 2011-04-04 | Genentech Inc | Composiciones y metodos para la prevencion de la degradacion oxidativa de proteinas. |
DK2370561T3 (da) | 2008-12-16 | 2019-10-21 | Emd Millipore Corp | Omrøringstankreaktor og fremgangsmåde |
WO2010074702A1 (en) | 2008-12-16 | 2010-07-01 | Millipore Corporation | Purification of proteins |
CA2752884A1 (en) | 2009-02-27 | 2010-09-02 | Genentech, Inc. | Methods and compositions for protein labelling |
SG178358A1 (en) | 2009-08-11 | 2012-03-29 | Genentech Inc | Production of proteins in glutamine-free cell culture media |
MX2012002565A (es) | 2009-09-01 | 2012-05-29 | Genentech Inc | Purificacion de proteina mejorada a traves de una elucion de proteina a modificada. |
SI2550018T1 (sl) | 2010-03-22 | 2019-05-31 | F. Hoffmann-La Roche Ag | Sestavki in metode, uporabni za stabilizacijo formulacij, ki vsebujejo beljakovine |
MX2012012743A (es) | 2010-05-03 | 2012-11-23 | Genentech Inc | Composiciones y metodos utiles para reducir la viscosidad de formulaciones que contienen proteina. |
EP3597671B1 (de) | 2010-05-17 | 2022-09-21 | EMD Millipore Corporation | Stimulusreaktive polymere zur aufreinigung von biomolekülen |
WO2011150241A2 (en) | 2010-05-28 | 2011-12-01 | Genentech, Inc. | Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase |
ES2880802T3 (es) | 2010-06-24 | 2021-11-25 | Hoffmann La Roche | Composiciones y procedimientos para estabilizar formulaciones que contienen proteínas |
JP2013537539A (ja) | 2010-08-13 | 2013-10-03 | ジェネンテック, インコーポレイテッド | 疾患の治療のためのIL−1β及びIL−18に対する抗体 |
WO2012030512A1 (en) | 2010-09-03 | 2012-03-08 | Percivia Llc. | Flow-through protein purification process |
EP2732021B1 (de) | 2011-07-08 | 2020-05-27 | EMD Millipore Corporation | Verbesserte tiefenfilter für biotechnologische einwegverfahren |
AU2012355356B2 (en) | 2011-12-22 | 2017-10-12 | Genentech, Inc. | Ion exchange membrane chromatography |
SI2831261T1 (en) | 2012-03-27 | 2018-01-31 | F.Hoffmann-La Roche | A process for the production of low-level recombinant proteins DHNA (1,4-dihydroxy-2-naphthoate) |
SG10201709555SA (en) | 2012-05-18 | 2017-12-28 | Genentech Inc | High-concentration monoclonal antibody formulations |
EP2934602B1 (de) | 2012-12-19 | 2019-02-27 | Genentech, Inc. | Verfahren und zusammensetzungen zur radiohalogen proteinmarkierung |
MX2017000231A (es) | 2014-07-09 | 2017-06-27 | Genentech Inc | Ajuste del ph para mejorar la recuperacion por descongelamiento de bancos de celulas. |
CA3019373A1 (en) | 2016-03-29 | 2017-10-05 | Geltor, Inc. | Expression of proteins in gram-negative bacteria wherein the ratio of periplasmic volume to cytoplasmic volume is between 0.5:1 and 10:1 |
CN110049778A (zh) | 2016-12-22 | 2019-07-23 | 豪夫迈·罗氏有限公司 | 减少冻干多肽重构时间的方法和制剂 |
US11180541B2 (en) | 2017-09-28 | 2021-11-23 | Geltor, Inc. | Recombinant collagen and elastin molecules and uses thereof |
PL3818078T3 (pl) | 2018-07-03 | 2024-04-29 | Bristol-Myers Squibb Company | Metody produkcji białek rekombinowanych |
US20210380923A1 (en) | 2018-10-10 | 2021-12-09 | Boehringer Ingelheim International Gmbh | Method for membrane gas transfer in high density bioreactor culture |
CA3133652A1 (en) | 2019-04-01 | 2020-10-08 | Genentech, Inc. | Compositions and methods for stabilizing protein-containing formulations |
AU2020270920A1 (en) | 2019-04-12 | 2021-11-04 | Geltor, Inc. | Recombinant elastin and production thereof |
US20220315887A1 (en) | 2019-08-01 | 2022-10-06 | Bristol-Myers Squibb Company | Methods of improving protein productivity in fed-batch cell cultures |
WO2022066595A1 (en) | 2020-09-22 | 2022-03-31 | Bristol-Myers Squibb Company | Methods for producing therapeutic proteins |
WO2023015234A1 (en) | 2021-08-05 | 2023-02-09 | Bristol-Myers Squibb Company | Cell culture methods for producing therapeutic proteins |
WO2023049687A1 (en) | 2021-09-21 | 2023-03-30 | Bristol-Myers Squibb Company | Methods of controlling the level of dissolved oxygen (do) in a solution comprising a recombinant protein in a storage container |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946788A (en) * | 1985-06-11 | 1990-08-07 | Ciba-Geigy Corporation | Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications |
US4714759A (en) * | 1985-12-02 | 1987-12-22 | Whitaker Jr Robert B | Immunotoxin therapy of allergy |
US4940782A (en) * | 1987-06-08 | 1990-07-10 | G. D. Searle & Co. | Monoclonal antibodies against IgE-associated determinants, hybrid cell lines producing these antibodies, and use therefore |
US4962035A (en) * | 1987-12-01 | 1990-10-09 | President And Fellows Of Harvard College | DNA encoding IgE receptor alpha-subunit or fragment thereof |
US5091313A (en) * | 1988-08-05 | 1992-02-25 | Tanox Biosystems, Inc. | Antigenic epitopes of IgE present on B cell but not basophil surface |
AU618317B2 (en) * | 1987-12-31 | 1991-12-19 | Tanox Biosystems, Inc. | Unique antigenic epitopes on ige-bearing b lymphocytes |
US5252467A (en) * | 1987-12-31 | 1993-10-12 | Tanox Biosystems, Inc. | Method of making antibodies to antigenic epitopes of IGE present on B cells but not basophil cell surface or secreted, soluble IGE |
JP2988635B2 (ja) * | 1990-09-18 | 1999-12-13 | 塩野義製薬株式会社 | ヒトIgEに対するモノクローナル抗体 |
JP3457962B2 (ja) * | 1991-08-14 | 2003-10-20 | ジェネンテク,インコーポレイテッド | 特定Fcεレセプターのための免疫グロブリン変異体 |
SE9102808L (sv) * | 1991-09-26 | 1993-03-27 | Lars T Hellman Inst F Immunolo | Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner |
-
1995
- 1995-01-05 JP JP51821495A patent/JP3825798B2/ja not_active Expired - Lifetime
- 1995-01-05 DK DK95907302T patent/DK0739214T3/da active
- 1995-01-05 AP APAP/P/1996/000875A patent/AP660A/en active
- 1995-01-05 AT AT95907302T patent/ATE164079T1/de not_active IP Right Cessation
- 1995-01-05 MX MX9602818A patent/MX9602818A/es unknown
- 1995-01-05 EP EP95907302A patent/EP0739214B1/de not_active Expired - Lifetime
- 1995-01-05 WO PCT/US1995/000087 patent/WO1995019181A1/en active IP Right Grant
- 1995-01-05 DE DE69501817T patent/DE69501817T2/de not_active Expired - Fee Related
- 1995-01-09 PH PH49755A patent/PH31447A/en unknown
- 1995-04-14 US US08/422,748 patent/US5656273A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
MX9602818A (es) | 1997-06-28 |
AP660A (en) | 1998-08-18 |
EP0739214A1 (de) | 1996-10-30 |
DK0739214T3 (da) | 1998-10-07 |
DE69501817T2 (de) | 1998-09-10 |
EP0739214B1 (de) | 1998-03-18 |
JP3825798B2 (ja) | 2006-09-27 |
AP9600875A0 (en) | 1997-01-31 |
DE69501817D1 (de) | 1998-04-23 |
US5656273A (en) | 1997-08-12 |
WO1995019181A1 (en) | 1995-07-20 |
PH31447A (en) | 1998-11-03 |
JPH10503749A (ja) | 1998-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE164079T1 (de) | Verfahren zur behandlung von parasitären infektionen unter verwendung von ige-antagonisten | |
DE69620848T2 (de) | Photolack-Entfernungslösung und Verfahren zur Entfernung von Photolack unter Verwendung derselben | |
DE69331469D1 (de) | Verfahren zur behandlung von abfällen | |
DE69701714T2 (de) | Verfahren zur behandlung von glassubstraten | |
DE69535022D1 (de) | Verfahren zur verbesserung von destillat | |
ATE225185T1 (de) | Verfahren zur behandlung von allergischem asthma | |
DE69507500T2 (de) | Verfahren zur behandlung von kunststoffgiessformen | |
DE69603838T2 (de) | Verfahren zur behandlung von gasen | |
DE59305971D1 (de) | Verfahren zur entölung von rohlecithin | |
DE59810532D1 (de) | Verfahren zur behandlung von cellulosischen formkörpern | |
ATE214388T1 (de) | Verfahren zur kristallisation von losartan | |
ATA124894A (de) | Verfahren zur direktreduktion von eisenoxidhältigem material | |
DE59807142D1 (de) | Verfahren zur reinigung von anlagenteilen | |
ATE371453T1 (de) | Verfahren zur behandlung von okularen neovaskularen erkrankungen | |
DE69514535D1 (de) | Verfahren zur raffinierung von methylal | |
DE69609082D1 (de) | Verfahren zur behandlung von abfällen | |
DE69824283D1 (de) | Verfahren zur reinigung von caprolactam | |
DE59507436D1 (de) | Verfahren zur direktreduktion von eisenoxidhältigem material | |
DE69802904D1 (de) | Verbessertes verfahren zur behandlung von aluminiummonohydratreichen bauxiten | |
DE59608741D1 (de) | Verfahren zur herstellung von optisch aktiven aminen | |
DE59709202D1 (de) | Verfahren zur herstellung von optisch aktiven aminen | |
DE59503391D1 (de) | Verfahren zur direktreduktion von eisenoxidhältigem material | |
DE69429341T2 (de) | Verfahren zur behandlung von flüssigkeiten | |
DE69533397D1 (de) | Verfahren zur behandlung von hypertonie | |
DE59901250D1 (de) | Verfahren zur thermischen behandlung von abfällen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |